Quality-of-Life Assessment for Fallopian Tube Cancer
This trial is studying two different symptom management programs to see how well they work compared with usual care in patients with ovarian cancer.
- Fallopian Tube Cancer
- Psychological Impact of Cancer
- Primary Peritoneal Carcinoma
- Recurrent Ovarian Cancer
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2022 Phase 3 trial • 87 Patients • NCT02066181
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Are there opportunities for individuals to join this medical investigation?
"According to clinicaltrials.gov, patient recruitment for this trial has concluded; the study was posted on January 19th 2010 and last modified March 8th 2019. However, there are 3293 other trials that still remain open to enrollment at present time."
How many health centers in the state are engaged with this research?
"This clinical trial is utilizing several locations across the United States, including Methodist West Hospital in West Des Moines, Iowa, Palo Alto Medical Foundation-Gynecologic Oncology in Mountain View, California and Kansas City NCI Community Oncology Research Program in Prairie Village, Kansas."